31,880 Results

Recruitment of extravascular fluid by hyperoncotic albumin

Fluid Management

Recruitment of extravascular fluid by hyperoncotic albumin

In 1896 Ernest Starling published his hypothesis for fluid exchange, whereby fluid exchange exists mainly in the capillaries through a process of plasma ultrafiltration across semipermeable membranes (Starling, 1896). But is this 19th century theory something of the past?

The FDA has agreed to a rolling submission for givosiran for acute hepatic porphyria.- Alnylam Pharma

 Added 14 hours ago

Alnylam Pharmaceuticals, Inc.has announced that in consultation with the FDA, the Company plans to pursue a full approval based on...

Anixa Biosciences has filed an IVD pre-submission with the FDA for use of its Cchek artificial intelligence based cancer detection technology, as a prostate cancer test.

 Added ago

Anixa Biosciences formerly ITUS Corporation , a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy...

European Commission approves Hulio (adalimumab biosimilar)for all indications of the reference drug.- Mylan + Fujifilm Kyowa Kirin Biologics.

 Added 14 hours ago

The European commission (EC) has granted marketing authorization to Mylan and Fujifilm Kyowa Kirin Biologics for Hulio, a biosimilar to...

FDA approves Yutiq for chronic non-infectious uveitis.- EyePoint Pharma.

 Added 14 hours ago

EyePoint Pharmaceuticals announced that the FDA has approved Yutiq (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious uveitis...

Phase III SAkuraSky Study shows SA 237 cuts risk of relapse in neuromyelitis optica.- Chugai Pharma.

 Added 14 hours ago

Chugai Pharmaceutical announced new results from the phase III study of SA 237 (satralizumab) SAkuraSky Study (NCT02028884) for the treatment...

FDA approves Xarelto to reduce the risk of CV events.- Bayer Healthcare + Janssen

 Added 14 hours ago

The FDA has approved rivaroxaban (Xarelto), 2.5 mg twice daily, plus aspirin low dose once daily to reduce the risk...

Phase III KATHERINE study of Kadcyla meets primary endpoint in HER2+ breast cancer.- Genentech/Roche.

 Added 14 hours ago

Genentech/Roche announced the Phase III KATHERINE study met its primary endpoint, showing Kadcyla (ado-trastuzumab emtansine) as a single agent significantly...

Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn’s disease

Inflammatory Bowel Disease Knowledge Centre

Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn’s disease

This study investigates the diagnostic performance of PET/MR and demonstrates that new non-invasive radiological techniques, which enable accurate detection of active inflammation, may play an increasingly important role in the management of Crohn’s disease.

Prothrombin complex concentrate reversal of coagulopathy in emergency general surgery patients

Oral Anticoagulation Reversal

Prothrombin complex concentrate reversal of coagulopathy in emergency general surgery patients

In this study, Younis et al. compared reversal agents administered to coagulopathic patients undergoing EGS hoping to uncover a solution to this complex problem.

Load more